BG

Bunge Global SA - Q1 2025 10-Q Summary

Business Context and Reporting Period

This report covers the quarterly period ended March 31, 2025. Bunge Global SA operates as a global agribusiness with three primary reportable segments: Agribusiness, Refined and Specialty Oils, and Milling. Effective January 1, 2025, the company reclassified its Sugar & Bioenergy operations into "Corporate and Other" following the sale of its 50% interest in BP Bunge Bioenergia. The company is currently pursuing a pending business combination with Viterra Limited, for which it has secured $5.8 billion in acquisition financing as of the reporting date.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 13% year-over-year to $11.6 billion, driven by lower volumes and average sales prices in the Agribusiness segment (down 16%) and Refined and Specialty Oils segment (down 5%).
• Profitability Pressure: Net income attributable to shareholders fell 18% to $201 million. Total EBIT declined 24% to $328 million, primarily due to lower gross profits in the Refined and Specialty Oils segment (EBIT down 49%) and Agribusiness segment (EBIT down 3%).
• Cash Flow Volatility: Operating cash flow swung from a $994 million inflow in Q1 2024 to a $285 million outflow in Q1 2025. This was primarily due to a $1.2 billion increase in inventory purchases related to the South American harvest timing.
• Debt Levels: Total debt increased to $6.7 billion, reflecting the issuance of $2.0 billion in Senior Notes in September 2024 to fund the Viterra acquisition and increased short-term borrowings for working capital.
• Foreign Exchange: The company recorded a net foreign exchange gain of $25 million in Q1 2025, compared to a loss of $78 million in the prior year, largely due to a weaker U.S. dollar impacting non-U.S. dollar functional currency operations.

Outlook, Risks, and Unusual Items

• Viterra Acquisition: The company is actively managing the closing of the Viterra acquisition. Financing commitments have been reduced to $5.8 billion following the divestment of 40% of Bunge Iberica SA (BISA) and the issuance of Senior Notes. A $400 million termination fee is payable if the deal fails due to antitrust issues.
• Divestitures: Bunge agreed to sell its North America corn milling business for approximately $450 million (expected to close mid-2025) and its European margarines and spreads business for approximately $239 million (expected to close in 2026).
• Dividend Policy: The company paid a quarterly dividend of $0.68 per share. Shareholders are scheduled to vote on a new annual dividend of $2.80 per share ($0.70 quarterly) in May 2025.
• Risks: Key risks include the outcome of regulatory approvals for the Viterra deal, volatility in agricultural commodity prices, foreign exchange fluctuations, and ongoing legal proceedings in Brazil (tax and labor claims totaling $267 million in reserves).
• Unusual Items: The company recognized a $95 million liability related to indemnities for the sale of BP Bunge Bioenergia. Additionally, the company collected a $52 million insurance recovery related to the Ukraine-Russia war in Q1 2025.

Investor Verification Checklist

• Verify the status of regulatory approvals for the Viterra Limited acquisition and potential impact on the $400 million termination fee.
• Monitor the timing and final proceeds of the North America corn milling and European margarines divestitures.
• Assess the sustainability of working capital requirements given the significant cash outflow from operations in Q1 2025 driven by inventory build-up.
• Review the exposure to Brazilian tax and labor claims, which remain a significant contingent liability.
• Confirm the execution of the proposed $0.70 quarterly dividend at the upcoming shareholder meeting.